Publications
326
Citations
486
Est. group size
~65
Recurring co-author estimate
Active years
8
Publishing since 2019
Rebecca Hoyd's research focuses on how microorganisms living within tumors and the gut interact with the immune system and cancer biology, using computational tools like RNA-sequencing analysis and survival modeling. Her work spans multiple cancer types, including breast, bladder, colon, lung, and kidney cancer, often examining how the tumor microbiome and metabolic environment affect responses to immunotherapy. This work is highly computational and data-driven, combining bioinformatics with clinical and biological datasets.
Publication output was minimal before 2019 but has grown sharply since, peaking dramatically in 2024, indicating a rapidly expanding and highly active research output in recent years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Breast tumor microbiome regulates anti-tumor immunity and T cell-associated metabolites
Scientific Reports · 2026
- mt.surv: Multi-Threshold Survival Analysis
2026
- IP77-26 DECODING THE TUMOR ECOSYSTEM: RNA-SEQ PROFILING REVEALS MICROBIOME–TME COUPLING IN BLADDER CANCER
The Journal of Urology · 2026
- Role of insulinemic and inflammatory dietary patterns on gut microbial composition and circulating biomarkers of metabolic health among older American men
Gut Microbes · 2025
- Colon cancer in Appalachian Kentucky: Unique genetic, microbiome and obesity findings in a cohort comparison
Human Genetics and Genomics Advances · 2025
- mt.surv: Multi-Threshold Survival Analysis for Associating Continuous Predictor Variables with Time-to-Event Outcomes
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Survival Disparity and the Unique Genomic and Microbiome Profiles of Colon Cancer in Appalachian Kentucky
Journal of the American College of Surgeons · 2025
- spakowiczlab/staph-brca: Breast tumor microbiome regulates anti-tumor immunity and T cell-associated metabolites, initial release
Zenodo (CERN European Organization for Nuclear Research) · 2025
- spakowiczlab/staph-brca: Breast tumor microbiome regulates anti-tumor immunity and T cell-associated metabolites, initial release
Zenodo (CERN European Organization for Nuclear Research) · 2025
- Dynamic human gut microbiome and immune shifts during an immersive psychosocial intervention program
Brain Behavior and Immunity · 2024
- Dynamic Human Gut Microbiome and Immune Shifts During an Immersive Psychosocial Therapeutic Program
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Abstract 7057: Validation of OXPHOS gene amplification as a driver of treatment resistance in non-small cell lung cancer
Cancer Research · 2024
- Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppression
JNCI Journal of the National Cancer Institute · 2023
- Abstract 5904: Intra-tumor microbes identified by RNAseq associated with response to immune checkpoint blockade in metastatic melanoma
Cancer Research · 2023
- Abstract 6574: Systematic analysis of the predictive gene expression signatures of immunotherapies across multiple cancer types using IOSig
Cancer Research · 2023
- Cancer Research×21
- Journal of Clinical Oncology×13
- bioRxiv (Cold Spring Harbor Laboratory)×9
- Cancer Research Communications×5
- Journal of Geriatric Oncology×5
- Daniel Spakowicz
Medicine · The Ohio State University
- Ning Jin
Medicine · The Ohio State University
- Gabriel Tinoco
Medicine · The Ohio State University
- Marium Husain
Medicine · The Ohio State University
- Qin Ma
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile